After an initial observation that HIV-tat protein derived peptides mediate an efficient cellular uptake of variable proteins, apparently there are not many clinical applications of this technology. What are the reasons for that?
CPP (cell penetrating peptides) have been investigated before HIV-Tat, and still there are people investigating these peptides. CPPs have good reasons to get avoided, since they are not targeted, and many studies were done to target CPP to the needed cell types. Here are some review and research studies in related topic: